These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8220018)

  • 1. [The distribution of hematoporphyrin derivatives in the animal body].
    Seĭlanov AS; Pyzhik VM; Seĭlanova IuA; Mironov AF; Deriuzhenko IV
    Eksp Klin Farmakol; 1993; 56(4):48-50. PubMed ID: 8220018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematoporphyrin derivatives: distribution in a living organism.
    Mironov AF; Seylanov AS; Seylanov JA; Pizhik VM; Deruzhenko IV; Nockel AJ
    J Photochem Photobiol B; 1992 Dec; 16(3-4):341-6. PubMed ID: 1479475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular accumulation and biological activity of hematoporphyrin derivative(L) in comparison with photofrin II.
    Khanum F; Jain V
    Indian J Exp Biol; 1997 Apr; 35(4):348-55. PubMed ID: 9315233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of haematoporphyrin analogues in a lung carcinoma model.
    Tronconi M; Colombo A; De Cesare M; Marchesini R; Woodburn KW; Reiss JA; Phillips DR; Zunino F
    Cancer Lett; 1995 Jan; 88(1):41-8. PubMed ID: 7850772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse.
    Bugelski PJ; Porter CW; Dougherty TJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4606-12. PubMed ID: 7306978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of the tumor-localizing components of hematoporphyrin derivative.
    Scourides PA; Böhmer RM; Kaye AH; Morstyn G
    Cancer Res; 1987 Jul; 47(13):3439-45. PubMed ID: 3581080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of hematoporphyrin derivative in normal and malignant tissue.
    Hara N; Ichinose Y; Motohiro A; Ohta M; Yagawa K
    Jpn J Exp Med; 1988 Jun; 58(3):139-43. PubMed ID: 2972857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-localizing components of the porphyrin preparation hematoporphyrin derivative.
    Kessel D; Chou TH
    Cancer Res; 1983 May; 43(5):1994-9. PubMed ID: 6831428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry and biological activity of hematoporphyrin derivative (HPD) and photofrin II on human cancerous cells.
    De Rosa A; De Simone F; Ramundo E; Rizzo A; Marziani R
    J Chemother; 1989 Jul; 1(4 Suppl):1148-50. PubMed ID: 16312811
    [No Abstract]   [Full Text] [Related]  

  • 10. [The pharmacokinetics of hematoporphyrin, its derivative and fluorescein during the development of carcinosarcoma].
    Barabash RD; Skobelkin OK; Petukhov MI; Normanskiĭ VE; Riazhskiĭ GG; Mironova MI; Andreeva KP; Kolobanov AS
    Farmakol Toksikol; 1990; 53(3):24-6. PubMed ID: 2143733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of porphyrin fluorescence in tissue samples of tumour-bearing mice.
    Cubeddu R; Canti G; Taroni P; Valentini G
    J Photochem Photobiol B; 1995 Aug; 29(2-3):171-8. PubMed ID: 7472811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-localizing and photosensitizing properties of the main components of hematoporphyrin derivative.
    Evensen JF; Sommer S; Moan J; Christensen T
    Cancer Res; 1984 Feb; 44(2):482-6. PubMed ID: 6229328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonodynamic therapy with photofrin II on AH130 solid tumor. Pharmacokinetics, tissue distribution and sonodynamic antitumoral efficacy of photofrin II.
    Yumita N; Umemura S
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):174-8. PubMed ID: 12647020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of 9L gliosarcomas to photodynamic therapy.
    Chopp M; Dereski MO; Madigan L; Jiang F; Logie B
    Radiat Res; 1996 Oct; 146(4):461-5. PubMed ID: 8927718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 tumor after a single intravenous injection.
    Doroshenko YM; Karavay AV; Hodysh YY; Uglyanitsa KN; Nowicky WM; Nefyodov LI
    Drugs Exp Clin Res; 2000; 26(5-6):171-7. PubMed ID: 11345024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Components of hematoporphyrin derivatives and their tumor-localizing capacity.
    Kessel D
    Cancer Res; 1982 May; 42(5):1703-6. PubMed ID: 7066890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence localization in tumour and normal brain after intratumoral injection of haematoporphyrin derivative into rat brain tumour.
    Hebeda KM; Wolbers JG; Sterenborg HJ; Kamphorst W; van Gemert MJ; van Alphen HA
    J Photochem Photobiol B; 1995 Jan; 27(1):85-92. PubMed ID: 7699526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.
    Hahn SM; Putt ME; Metz J; Shin DB; Rickter E; Menon C; Smith D; Glatstein E; Fraker DL; Busch TM
    Clin Cancer Res; 2006 Sep; 12(18):5464-70. PubMed ID: 17000681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of porphyrin modified photosensitizer porfimer sodium and its precursors by high performance liquid chromatography and mass spectrometry.
    Stoev G; Stoyanov A; Shopova M; Dachev K
    J Chromatogr A; 2007 Mar; 1145(1-2):141-8. PubMed ID: 17303147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of hydrazine sulfate in intact and tumor-bearing rats].
    Filov VA; Popov BV; Bezel' VS
    Farmakol Toksikol; 1982; 45(4):78-81. PubMed ID: 7128794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.